SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
SC TO-T

Tender offer schedule and amendment filed by a third party.

Mergers & Acquisitions
View HTML
SC TO-T

Tender offer schedule and amendment filed by a third party.

Mergers & Acquisitions
View HTML
15-12B

Termination of registration under Section 12(g) or suspension of duty to file reports

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML

Data provided by Kaleidoscope.